JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB109732

Anti-FBP1 antibody [EPR4620]

5

(1 Review)

|

(24 Publications)

Rabbit Recombinant Monoclonal FBP1 antibody. Suitable for WB, ICC/IF, Flow Cyt (Intra) and reacts with Human, Recombinant full length protein - Human, Mouse, Rat samples. Cited in 24 publications.

View Alternative Names

FBP, FBP1, FBPase 1, Liver FBPase

7 Images
Flow Cytometry (Intracellular) - Anti-FBP1 antibody [EPR4620] (AB109732)
  • Flow Cyt (Intra)

Unknown

Flow Cytometry (Intracellular) - Anti-FBP1 antibody [EPR4620] (AB109732)

Intracellular Flow Cytometry analysis of MCF7 (Human breast adenocarcinoma epithelial cell) cells labeling FBP1 with purified ab109732 at 1/400 dilution (1 μg/ml) (red). Cells were fixed with 4% Paraformaldehyde. A Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) secondary antibody was used at 1/2000. Isotype control - Rabbit monoclonal IgG (Black). Unlabeled control - Cell without incubation with primary antibody and secondary antibody (Blue).

Immunocytochemistry/ Immunofluorescence - Anti-FBP1 antibody [EPR4620] (AB109732)
  • ICC/IF

Collaborator

Immunocytochemistry/ Immunofluorescence - Anti-FBP1 antibody [EPR4620] (AB109732)

ICC/IF image of ab109732 stained HeLa cells. The cells were 4% formaldehyde fixed (10 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab109732, 10μg/ml) overnight at +4°C. The secondary antibody (green) was ab96899, DyLight® 488 goat anti-rabbit IgG (H+L) used at a 1/250 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43μM.

Immunocytochemistry/ Immunofluorescence - Anti-FBP1 antibody [EPR4620] (AB109732)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-FBP1 antibody [EPR4620] (AB109732)

Immunocytochemistry/ Immunofluorescence analysis of HeLa (Human cervix adenocarcinoma epithelial cell) cells labeling FBP1 with purified ab109732 at 1 : 50 dilution (7.9 µg/ml). Cells were fixed in 4% Paraformaldehyde and permeabilized with 0.1% tritonX-100. Cells were counterstained with ab195889 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) 1 : 200 (2.5 µg/ml). Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) was used as the secondary antibody at 1 : 1000 (2 µg/ml) dilution. DAPI nuclear counterstain. PBS instead of the primary antibody was used as the secondary antibody only control.

Western blot - Anti-FBP1 antibody [EPR4620] (AB109732)
  • WB

Unknown

Western blot - Anti-FBP1 antibody [EPR4620] (AB109732)

All lanes:

Western blot - Anti-FBP1 antibody [EPR4620] (ab109732) at 1/1000 dilution

Lane 1:

Human stomach lysate at 10 µg

Lane 2:

Human fetal liver lysate at 10 µg

Lane 3:

MCF7 lysate at 10 µg

Predicted band size: 37 kDa

false

Western blot - Anti-FBP1 antibody [EPR4620] (AB109732)
  • WB

Supplier Data

Western blot - Anti-FBP1 antibody [EPR4620] (AB109732)

Blocking buffer and concentration :  5% NFDM/TBST.  Diluting buffer and concentration :  5% NFDM/TBST.

All lanes:

Western blot - Anti-FBP1 antibody [EPR4620] (ab109732) at 1/1000 dilution

Lane 1:

DDDK-tagged FBP1 human full-length recombinant protein at 15 ng

Lane 2:

DDDK-tagged FBP2 human full-length recombinant protein at 15 ng

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 37 kDa

Observed band size: 37 kDa

false

Exposure time: 5s

Western blot - Anti-FBP1 antibody [EPR4620] (AB109732)
  • WB

Lab

Western blot - Anti-FBP1 antibody [EPR4620] (AB109732)

All lanes:

Western blot - Anti-FBP1 antibody [EPR4620] (ab109732) at 1/50000 dilution

All lanes:

MCF7 (Human breast adenocarcinoma epithelial cell) whole cell lysates at 15 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 37 kDa

Observed band size: 36 kDa

false

Western blot - Anti-FBP1 antibody [EPR4620] (AB109732)
  • WB

Lab

Western blot - Anti-FBP1 antibody [EPR4620] (AB109732)

All lanes:

Western blot - Anti-FBP1 antibody [EPR4620] (ab109732) at 1/1000 dilution

Lane 1:

Human kidney lysates at 20 µg

Lane 2:

Mouse liver lysates at 20 µg

Lane 3:

Mouse kidney lysates at 20 µg

Lane 4:

Rat liver lysates at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 37 kDa

Observed band size: 36 kDa

false

  • Carrier free

    Anti-FBP1 antibody [EPR4620] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR4620

Isotype

IgG

Carrier free

No

Reacts with

Mouse, Rat, Human

Applications

ICC/IF, WB, Flow Cyt (Intra)

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/10000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "10 µg/mL", "ICCIF-species-notes": "<p></p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "1/400", "FlowCytIntra-species-notes": "<p></p>" }, "Mouse": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/10000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "FlowCytIntra-species-checked": "guaranteed", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "" }, "Rat": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/10000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "FlowCytIntra-species-checked": "guaranteed", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "" }, "Recombinant full length protein - Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "FlowCytIntra-species-checked": "notRecommended", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "" } } }

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Storage information
Stable for 12 months at -20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

FBP1 also known as fructose-16-bisphosphatase 1 is an enzyme with a molecular mass of approximately 37 kDa. It plays a mechanical role in catalyzing the conversion of fructose-16-bisphosphate to fructose 6-phosphate in the gluconeogenesis pathway. This enzyme expresses primarily in the liver but also in kidneys and muscles reflecting its key role in glucose metabolism.
Biological function summary

The function of FBP1 involves maintaining glucose homeostasis which is essential for energy balance. FBP1 is part of the gluconeogenesis pathway a process that synthesizes glucose from non-carbohydrate sources. This enzyme acts independently and does not usually form part of larger protein complexes but its activity significantly impacts liver metabolism and energy production in low-glucose conditions.

Pathways

FBP1 finds its primary involvement in the gluconeogenesis pathway. This roles complements those of other enzymes such as phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase which also contribute to glucose synthesis. FBP1's activity supports glucose production providing glucose for bloodstream circulation when dietary intake is low.

FBP1's function directly relates to conditions such as fructose 16-bisphosphatase deficiency and has implications in type 2 diabetes. Deficient FBP1 can lead to life-threatening hypoglycemia demonstrating the need for energy regulation by this enzyme. Its regulation intersects with insulin signaling pathways with proteins like insulin receptor substrate (IRS) playing roles in modulating its activity in metabolic disorders.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Catalyzes the hydrolysis of fructose 1,6-bisphosphate to fructose 6-phosphate in the presence of divalent cations, acting as a rate-limiting enzyme in gluconeogenesis. Plays a role in regulating glucose sensing and insulin secretion of pancreatic beta-cells. Appears to modulate glycerol gluconeogenesis in liver. Important regulator of appetite and adiposity; increased expression of the protein in liver after nutrient excess increases circulating satiety hormones and reduces appetite-stimulating neuropeptides and thus seems to provide a feedback mechanism to limit weight gain.
See full target information FBP1

Publications (24)

Recent publications for all applications. Explore the full list and refine your search

Nature metabolism 7:1991-2003 PubMed40968275

2025

Redox-dependent liver gluconeogenesis impacts different intensity exercise in mice.

Applications

Unspecified application

Species

Unspecified reactive species

Takahiro Horiuchi,Keizo Kaneko,Shinichiro Hosaka,Kenji Uno,Seitaro Tomiyama,Kei Takahashi,Maya Yamato,Akira Endo,Hiroto Sugawara,Yohei Kawana,Yoichiro Asai,Shinjiro Kodama,Junta Imai,Seiya Mizuno,Satoru Takahashi,Atsushi Takasaki,Hiraku Ono,Koutaro Yokote,Rae Maeda,Yuki Sugiura,Hideki Katagiri

Oncogenesis 14:11 PubMed40263262

2025

O-GlcNAcylation of FBP1 promotes pancreatic cancer progression by facilitating its Lys48-linked polyubiquitination in hypoxic environments.

Applications

Unspecified application

Species

Unspecified reactive species

Yi Zhu,Xiaoman He,Xiaojing Ma,Yan Zhang,Wei Feng

BMC medical genomics 18:17 PubMed39849455

2025

Identification of a novel heterozygous GPD1 missense variant in a Chinese adult patient with recurrent HTG-AP consuming a high-fat diet and heavy smoking.

Applications

Unspecified application

Species

Unspecified reactive species

Xiao-Yao Li,Bei-Yuan Zhang,Xin-Ran Liang,Yan-Yu Han,Min-Hua Cheng,Mei Wei,Ke Cao,Xian-Cheng Chen,Ming Chen,Jian-Feng Duan,Wen-Kui Yu

Translational andrology and urology 13:1991-2004 PubMed39434735

2024

TRIM47 promotes the Warburg effect and reduces ferroptosis in prostate cancer by FBP1 and FOXO1.

Applications

Unspecified application

Species

Unspecified reactive species

Chubiao Zhao,Zengqin Liu,Junming Peng,Jiansheng Huang,Jinan Guo

Cardiovascular diabetology 23:358 PubMed39395983

2024

Spatial multiomics atlas reveals smooth muscle phenotypic transformation and metabolic reprogramming in diabetic macroangiopathy.

Applications

Unspecified application

Species

Unspecified reactive species

Yongjiang Qian,Shizheng Xiong,Lihua Li,Zhen Sun,Lili Zhang,Wei Yuan,Honghua Cai,Guoquan Feng,Xiaoguang Wang,Haipeng Yao,Yun Gao,Li Guo,Zhongqun Wang

Nutrition & metabolism 19:78 PubMed36447227

2022

Preoperative administration of branched-chain amino acids reduces postoperative insulin resistance in rats by reducing liver gluconeogenesis.

Applications

Unspecified application

Species

Unspecified reactive species

Jin Zhang,Rui Chi,Yunpeng Zhang,Yi Xie,Yunxia Liu,Qun Bao,Hengyu Lv,Bo Han,Haipeng Sun,Peng Sun

Annals of translational medicine 9:1701 PubMed34988210

2022

Andrographolide inhibits non-small cell lung cancer cell proliferation through the activation of the mitochondrial apoptosis pathway and by reprogramming host glucose metabolism.

Applications

Unspecified application

Species

Unspecified reactive species

Zhao Chen,Wei-Jian Tang,Yu-Han Zhou,Zhou-Miao Chen,Kai Liu

Central-European journal of immunology 46:427-437 PubMed35125940

2021

Gastric cancer mesenchymal stem cells inhibit natural killer cell function by up-regulating FBP1.

Applications

Unspecified application

Species

Unspecified reactive species

Fengfeng Han,Shuwei Guo,Chao Huang,Linjing Cui,Yuanyuan Zhao,Jie Ma,Miaolin Zhu,Zhihong Chen,Mei Wang,Bo Shen,Wei Zhu

Molecular oncology 16:1591-1607 PubMed34854226

2021

Deubiquitination of FBP1 by USP7 blocks FBP1-DNMT1 interaction and decreases the sensitivity of pancreatic cancer cells to PARP inhibitors.

Applications

Unspecified application

Species

Unspecified reactive species

Xiang Cheng,Bin Zhang,Feng Guo,Heshui Wu,Xin Jin

Computational and mathematical methods in medicine 2021:3334065 PubMed34221105

2021

miR-18a-5p Targets FBP1 to Promote Proliferation, Migration, and Invasion of Liver Cancer Cells and Inhibit Cell Apoptosis.

Applications

Unspecified application

Species

Unspecified reactive species

Shan Gao,Dongjie Zhu,Jian Zhu,Lianqiang Shen,Ming Zhu,Xuefeng Ren
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com